Table 3.
Clinicopathological characteristics of NSCLC patients who received chemotherapy
| Total (N=43) | |
|---|---|
| Age, years | 49–80 (mean 70) |
| Gender | Male (n=33) |
| Female (n=10) | |
| BI | <400 (n=10) |
| ≥400 (n=33) | |
| Histology | Ad (n=19) |
| Sq (n=18) | |
| Other (n=6) | |
| Stage | IIIA (n=5) |
| IIIB/IV (n=27) | |
| Post-operative recurrence (n=11) | |
| Specimen | TBB, TBLB (n=12) |
| CT-guided lung biopsy (n=3) | |
| EBUS-TBNA (LNs) (n=13) | |
| Surgical specimen (n=15) |
Abbreviations: NSCLC, non-small-cell lung cancer; BI, Brinkman index; Ad, adenocarcinoma; Sq, squamous cell carcinoma; TBB, transbronchial biopsy; TBLB, transbronchial lung biopsy; CT, computed tomography; EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration; LNs, lymph nodes.